In a recent interview with Impact Loop, Stratipath co-founder Johan Hartman shared exciting insights into Stratipath’s role in transforming cancer care:
“We have the first product in this field approved for hospital use. But AI is advancing rapidly, so there will be competition, which is great. The market is large, so there’s room for more players.”
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. More information about our Cookie Policy and Privacy policy.